ELRINGKLINGER AG (ZIL2.DE) Fundamental Analysis & Valuation

FRA:ZIL2 • DE0007856023

Current stock price

5.37 EUR
0 (0%)
Last:

This ZIL2.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ZIL2.DE Profitability Analysis

1.1 Basic Checks

  • ZIL2 had negative earnings in the past year.
  • In the past year ZIL2 had a positive cash flow from operations.
  • The reported net income has been mixed in the past 5 years: ZIL2 reported negative net income in multiple years.
  • Each year in the past 5 years ZIL2 had a positive operating cash flow.
ZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

1.2 Ratios

  • The Return On Assets of ZIL2 (-0.33%) is worse than 61.29% of its industry peers.
  • ZIL2's Return On Equity of -1.02% is on the low side compared to the rest of the industry. ZIL2 is outperformed by 61.29% of its industry peers.
  • ZIL2's Return On Invested Capital of 1.12% is on the low side compared to the rest of the industry. ZIL2 is outperformed by 80.65% of its industry peers.
  • ZIL2 had an Average Return On Invested Capital over the past 3 years of 3.71%. This is significantly below the industry average of 9.75%.
Industry RankSector Rank
ROA -0.33%
ROE -1.02%
ROIC 1.12%
ROA(3y)-2.07%
ROA(5y)-1.58%
ROE(3y)-6%
ROE(5y)-4.53%
ROIC(3y)3.71%
ROIC(5y)3.71%
ZIL2.DE Yearly ROA, ROE, ROICZIL2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -10 -20

1.3 Margins

  • The Operating Margin of ZIL2 (1.18%) is worse than 80.65% of its industry peers.
  • ZIL2's Operating Margin has improved in the last couple of years.
  • ZIL2 has a Gross Margin (22.90%) which is in line with its industry peers.
  • ZIL2's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 1.18%
PM (TTM) N/A
GM 22.9%
OM growth 3Y-3.24%
OM growth 5Y6.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y3.54%
ZIL2.DE Yearly Profit, Operating, Gross MarginsZIL2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. ZIL2.DE Health Analysis

2.1 Basic Checks

  • ZIL2 has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ZIL2 has about the same amount of shares outstanding.
  • ZIL2 has about the same amout of shares outstanding than it did 5 years ago.
  • ZIL2 has a worse debt/assets ratio than last year.
ZIL2.DE Yearly Shares OutstandingZIL2.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
ZIL2.DE Yearly Total Debt VS Total AssetsZIL2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • Based on the Altman-Z score of 1.55, we must say that ZIL2 is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.55, ZIL2 is not doing good in the industry: 64.52% of the companies in the same industry are doing better.
  • The Debt to FCF ratio of ZIL2 is 17.13, which is on the high side as it means it would take ZIL2, 17.13 years of fcf income to pay off all of its debts.
  • The Debt to FCF ratio of ZIL2 (17.13) is worse than 70.97% of its industry peers.
  • ZIL2 has a Debt/Equity ratio of 0.62. This is a neutral value indicating ZIL2 is somewhat dependend on debt financing.
  • ZIL2 has a Debt to Equity ratio of 0.62. This is in the better half of the industry: ZIL2 outperforms 61.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 17.13
Altman-Z 1.55
ROIC/WACC0.18
WACC6.42%
ZIL2.DE Yearly LT Debt VS Equity VS FCFZIL2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

2.3 Liquidity

  • A Current Ratio of 1.26 indicates that ZIL2 should not have too much problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 1.26, ZIL2 is in line with its industry, outperforming 51.61% of the companies in the same industry.
  • A Quick Ratio of 0.60 indicates that ZIL2 may have some problems paying its short term obligations.
  • ZIL2 has a worse Quick ratio (0.60) than 74.19% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.6
ZIL2.DE Yearly Current Assets VS Current LiabilitesZIL2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

4

3. ZIL2.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 95.54% over the past year.
  • The Revenue has decreased by -9.00% in the past year.
  • ZIL2 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.08% yearly.
EPS 1Y (TTM)95.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.86%
Revenue 1Y (TTM)-9%
Revenue growth 3Y-3.01%
Revenue growth 5Y2.08%
Sales Q2Q%-8.42%

3.2 Future

  • Based on estimates for the next years, ZIL2 will show a very strong growth in Earnings Per Share. The EPS will grow by 119.82% on average per year.
  • Based on estimates for the next years, ZIL2 will show a small growth in Revenue. The Revenue will grow by 4.28% on average per year.
EPS Next Y369.8%
EPS Next 2Y176.58%
EPS Next 3Y119.82%
EPS Next 5YN/A
Revenue Next Year2.36%
Revenue Next 2Y3.53%
Revenue Next 3Y4.5%
Revenue Next 5Y4.28%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
ZIL2.DE Yearly Revenue VS EstimatesZIL2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 500M 1B 1.5B 2B
ZIL2.DE Yearly EPS VS EstimatesZIL2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 -0.5 1

More info and screens

Find the best growth stocksShow best growing peers

4

4. ZIL2.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ZIL2. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 9.09, the valuation of ZIL2 can be described as reasonable.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ZIL2 indicates a somewhat cheap valuation: ZIL2 is cheaper than 70.97% of the companies listed in the same industry.
  • ZIL2 is valuated cheaply when we compare the Price/Forward Earnings ratio to 38.20, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 9.09
ZIL2.DE Price Earnings VS Forward Price EarningsZIL2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • ZIL2's Enterprise Value to EBITDA ratio is in line with the industry average.
  • 64.52% of the companies in the same industry are cheaper than ZIL2, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 14.49
EV/EBITDA 4.42
ZIL2.DE Per share dataZIL2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as ZIL2's earnings are expected to grow with 119.82% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y176.58%
EPS Next 3Y119.82%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. ZIL2.DE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 3.48%, ZIL2 has a reasonable but not impressive dividend return.
  • Compared to an average industry Dividend Yield of 3.36, ZIL2 has a dividend in line with its industry peers.
  • ZIL2's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 3.48%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years4
ZIL2.DE Yearly Dividends per shareZIL2.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.05 0.1

5.3 Sustainability

DP0%
EPS Next 2Y176.58%
EPS Next 3Y119.82%
ZIL2.DE Yearly Income VS Free CF VS DividendZIL2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M -100M

More info and screens

Find the best dividend stocksShow peers with best dividend

ZIL2.DE Fundamentals: All Metrics, Ratios and Statistics

ELRINGKLINGER AG

FRA:ZIL2 (4/15/2026, 7:00:00 PM)

5.37

0 (0%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)03-26
Earnings (Next)05-07
Inst Owners3.59%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap340.24M
Revenue(TTM)1.64B
Net Income(TTM)-6.15M
Analysts76.36
Price Target5.04 (-6.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.48%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.44%
PT rev (3m)-3.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)6.12%
EPS NY rev (3m)6.12%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.7%
Revenue NY rev (3m)-0.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 9.09
P/S 0.21
P/FCF 14.49
P/OCF 1.9
P/B 0.56
P/tB 0.69
EV/EBITDA 4.42
EPS(TTM)-0.1
EYN/A
EPS(NY)0.59
Fwd EY11.01%
FCF(TTM)0.37
FCFY6.9%
OCF(TTM)2.83
OCFY52.7%
SpS25.9
BVpS9.55
TBVpS7.8
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -0.33%
ROE -1.02%
ROCE 1.61%
ROIC 1.12%
ROICexc 1.24%
ROICexgc 1.38%
OM 1.18%
PM (TTM) N/A
GM 22.9%
FCFM 1.43%
ROA(3y)-2.07%
ROA(5y)-1.58%
ROE(3y)-6%
ROE(5y)-4.53%
ROIC(3y)3.71%
ROIC(5y)3.71%
ROICexc(3y)4.12%
ROICexc(5y)4.09%
ROICexgc(3y)4.67%
ROICexgc(5y)4.68%
ROCE(3y)5.38%
ROCE(5y)5.38%
ROICexgc growth 3Y1.29%
ROICexgc growth 5Y11.97%
ROICexc growth 3Y1.47%
ROICexc growth 5Y13.29%
OM growth 3Y-3.24%
OM growth 5Y6.95%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5%
GM growth 5Y3.54%
F-Score4
Asset Turnover0.87
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 17.13
Debt/EBITDA 2.69
Cap/Depr 128.33%
Cap/Sales 9.5%
Interest Coverage 0.72
Cash Conversion 127.39%
Profit Quality N/A
Current Ratio 1.26
Quick Ratio 0.6
Altman-Z 1.55
F-Score4
WACC6.42%
ROIC/WACC0.18
Cap/Depr(3y)84.44%
Cap/Depr(5y)74.59%
Cap/Sales(3y)7.35%
Cap/Sales(5y)6.51%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)95.54%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%103.86%
EPS Next Y369.8%
EPS Next 2Y176.58%
EPS Next 3Y119.82%
EPS Next 5YN/A
Revenue 1Y (TTM)-9%
Revenue growth 3Y-3.01%
Revenue growth 5Y2.08%
Sales Q2Q%-8.42%
Revenue Next Year2.36%
Revenue Next 2Y3.53%
Revenue Next 3Y4.5%
Revenue Next 5Y4.28%
EBIT growth 1Y112.89%
EBIT growth 3Y-6.15%
EBIT growth 5Y9.17%
EBIT Next Year345.81%
EBIT Next 3Y83.87%
EBIT Next 5YN/A
FCF growth 1Y-38.41%
FCF growth 3Y34.76%
FCF growth 5Y-30.69%
OCF growth 1Y6.73%
OCF growth 3Y20.98%
OCF growth 5Y-3.81%

ELRINGKLINGER AG / ZIL2.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ELRINGKLINGER AG?

ChartMill assigns a fundamental rating of 3 / 10 to ZIL2.DE.


What is the valuation status for ZIL2 stock?

ChartMill assigns a valuation rating of 4 / 10 to ELRINGKLINGER AG (ZIL2.DE). This can be considered as Fairly Valued.


What is the profitability of ZIL2 stock?

ELRINGKLINGER AG (ZIL2.DE) has a profitability rating of 3 / 10.


What is the financial health of ELRINGKLINGER AG (ZIL2.DE) stock?

The financial health rating of ELRINGKLINGER AG (ZIL2.DE) is 2 / 10.